Gunderson Dettmer advised Parallel Bio on the deal. Parallel Bio, a biotechnology company, announced its $4.3 million seed round led by Refactor Capital. Parallel Bio created a...
Gunderson Dettmer advised Parallel Bio on the deal. Parallel Bio, a biotechnology company, announced its $4.3 million seed round led by Refactor Capital. Parallel Bio created a...
You must be a Standard 1 Year member to access this content.